US Patent 7288530 Antisense modulation of survivin expression
Patent 7288530 was granted and assigned to Ionis Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 8, 2004
Date of Patent
October 30, 2007
Patent Application Number
10983392
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7288530 Antisense modulation of survivin expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
